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Follicular (FO) and marginal zone (MZ) B cells are
maintained in distinct locations within the spleen,
but the genetic basis for this separation is still enig-
matic. We now report that B cell sequestration
requires lineage-specific regulation of migratory
receptors by the transcription factor Klf2. Moreover,
using gene-targeted mice we show that altered
splenic B cell migration confers a significant in vivo
gain-of-function phenotype to FO B cells, including
the ability to quickly respond to MZ-associated anti-
gens and pathogens in a T cell-dependent manner.
This work demonstrates that in wild-type animals,
naive FO B cells are actively removed from the MZ,
thus restricting their capacity to respond to blood-
borne pathogens.
INTRODUCTION
The B cell compartment is composed of three mature lympho-
cyte lineages: B1 B cells (Fagarasan et al., 2000), B2 marginal
zone (MZ) B cells (Lopes-Carvalho and Kearney, 2004; Martin
and Kearney, 2002), and B2 follicular (FO) B cells (Okada and
Cyster, 2006). All three lineages are located in distinct
anatomical sites that contribute to their unique humoral func-
tions. B1 B cells are found in the pleural and peritoneal cavities
and respond to invading bacteria within the gut. Mature MZ B
cells reside within the splenic white pulp, directly adjacent to
the marginal sinus in the MZ. These cells come in direct contact
with slow-flowing blood and typically respond to blood-borne
pathogens. In adult mice, B1 B cells and MZ B cells act to
mediate the initial wave of humoral immunity against invading
pathogens by quickly producing antigen-specific antibodies in
a thymus-independent (TI) fashion. In sharp contrast, FO B cells
circulate between the blood and spleen and comprise the
majority of B cells found in peripheral lymph nodes. These cells
rely on thymus dependent (TD) signals to respond to antigen
and are located adjacent to T cell-rich areas in secondary
lymphoid organs. How these B cell lineages remain compart-
mentalized is the subject of intense research.
A major challenge is to determine the mechanisms by which B
cell migration is transcriptionally controlled. Quiescent B cells254 Immunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc.express Kruppel-like factor 2 (Klf2), a transcription factor previ-
ously implicated in naive T cell cycling (Buckley et al., 2001;
Kuo et al., 1997b) and trafficking (Carlson et al., 2006; Sebzda
et al., 2008). To determine whether this factor was similarly
required within the B cell lineage, we excised Klf2 in a B cell-spe-
cific manner. We discovered that Klf2 differentially regulates FO
and MZ B cell migratory receptors and that loss of Klf2 causes
a blurring of MZ and FO B cell separation within the spleen. As
a result of this migratory defect, Klf2-deficient FO B cells gain
the ability to respond toMZ-associated antigens and pathogens.
This study indicates that Klf2 supports lineage-specific B cell
homeostatic trafficking patterns and, in the case of FO B cells,
restricts antigen recognition within the spleen.RESULTS
Klf2-Deficient BCells Prematurely Exit theBoneMarrow
Klf2 expression is first detected in the B cell compartment after
productive pre-B cell receptor signaling in small resting pre-B
lymphocytes (Schuh et al., 2008). This transcription factor is
preferentially expressed in quiescent B cells (Bhattacharya
et al., 2007; Fruman et al., 2002; Glynne et al., 2000), and we
found that several factors that induce B cell activation quickly
downregulated Klf2 expression (Figure S1A available online).
Although transcription varied between B cell lineages (e.g.,
naive FO B cell express 2.53 more Klf2 than MZ B cells,
p = 0.004), all three cell types efficiently extinguished Klf2
expression following B cell-receptor stimulation (Figure S1B).
To better understand the role of Klf2 within the B cell compart-
ment, we crossed loxP-flanked Klf2 mice with gene-targeted
animals expressing Cre under the CD19 promoter (Klf2fl/fl;
Cd19-Cre+/). As expected, efficient Klf2 excision was
observed exclusively in B cells, both at the transcriptional
(Figure S1C) and translational level (Figure S1D). Flow cytomet-
ric analysis of bone marrow cells indicated that Klf2-deficient B
cell development up to the immature B cell stage was normal,
both in terms of surface receptors and absolute cell numbers
(Figure 1A). In contrast, fewer transitional or recirculating Klf2-
deficient B cells were detected. Both T1 (AA4+IgM+CD23)
and T2 (AA4+IgM+CD23+) transitional B cell numbers were
increased in spleens from genetically targeted animals
(Figure 1B), suggesting that Klf2 excision did not block late
stages of B cell development but instead played a role in imma-
ture B cell retention within the bone marrow.
Figure 1. Klf2fl/fl; CD19-cre+/ Mice Have
Decreased Numbers of Mature B Cells in
the Bone Marrow but Increased Numbers
of Transitional B Cells in the Spleen
(A) Transitional and mature B cell numbers
are reduced in bone marrow of genetically tar-
geted mice. The left panels show B cell differenti-
ation within the bone marrow of Klf2fl/fl; Cd19-
Cre+/ (cKO = genetically targeted) and Klf2+/+;
Cd19-Cre+/ (control) mice, whichwas analyzed by
flow cytometry with surface markers that distin-
guish betweenPro-B + Pre-B cells (B220lowIgMlow),
immature B cells (B220int-hiIgMint), transitional B
cells (B220intIgMhi), and mature + recirculating B
cells (B220hiIgMint). The right panels show transi-
tional (AA4.1+ IgMhiIgDint) and mature + recirculat-
ing (AA4.1IgMintIgDhi) B cells, which were reana-
lyzed with an alternative staining technique.
Numbers are B cell percentages within each
compartment; absolute cell numbers are dis-
played in the corresponding bar graph. (Pro +
Pre, Pro-B and Pre-B cells; Imm., immature B
cells; Trans., transitional B cells; and Recirc., recir-
culating B cells) Note that Pro+Pre B cell numbers
are displayed on a different scale (3107). n = 4
animals per group. p > 0.05 for Pro + Pre and
Imm. B cell stages. Error bars indicate the stan-
dard deviation.
(B) Transitional B cell stages (B220+AA4.1+) within
the spleen of cKO and control mice were
examined by flow cytometry and corresponding
absolute cell numbers, and p values are listed
in the adjoining bar graph. Percentages of T1
(AA4.1+B220+IgMhiCD23low) and T2 (AA4.1+
B220+IgMhiCD23hi) B cells are displayed in the
contour plots. n = 8 animals per group. Error
bars indicate the standard deviation.
Immunity
Klf2 Regulates B Cell Homing PatternsGenetically Targeted Mice Have Increased Numbers
of Splenic B Cells
The mature splenic B cell compartment is composed of circu-
lating FO B cells and noncirculating MZ B cells. As shown in
Figure 2A, genetically targetedmice had an increased proportion
of MZ B cells (AA4.1CD21hiIgMhi) relative to control littermates
(Klf2+/+; Cd19-Cre-cre+/ or Klf2fl/+; Cd19-Cre+/). In fact, both
FO and MZ B cell numbers were significantly increased in the
spleens of genetically targeted animals (Figure 2B). To ensure
that lymphocytes were correctly identified, we reanalyzed the
B cell compartment using additional staining techniques. First,
circulating FO B cells were identified in mesenteric lymph nodes
of control animals, which are known to lack MZ B cells (Allman
and Pillai, 2008), with antibodies directed against CD21, CD23,
and IgM (Figure S2A). A similar cell population, which expresses
slightly higher levels of CD21, was then identified in lymph nodes
of genetically targeted mice. These gating parameters were
transferred to the splenic B cell compartment to demarcate
FO B cells. MZ B cell populations were then gated in relation to
the FO B cell compartment (Figure S2B). To ensure that CD23+
MZ B cell precursors were not mistakenly identified as FO Bcells, splenocytes were stained with a combination of antibodies
to distinguish MZ B cell precursors from MZ and FO B cells
(Srivastava et al., 2005). Similar to transitional B cell stages,
genetically targeted mice had relatively normal frequencies of
MZ B cell precursors (Figure S2C), which translated into signifi-
cantly increased cell numbers (control = 2.8 ± 1.7 3 106, genet-
ically targeted mice = 13.1 ± 5.8 3 106, p = 0.005). FO-II B cells
(AA4.1+ CD19+ IgMhi IgDhi CD21int CD23+), which are speculated
to act as a reservoir for MZ precursors (Cariappa et al., 2007),
were not affected by the loss of Klf2 (control = 3.1 ± 1.4 3 106,
genetically targeted mice = 3.9 ± 2.2 3 106, p = 0.56). Both
Klf2+ and Klf2-deficient FO B cells (FO-I cells) displayed similar
staining patterns for IgD, CD1d, and CD9 (Figure S2D), which
were distinct from Klf2+ and Klf2-deficient MZ B cell precursors.
These conserved surface markers (Figure S2E) confirmed that
FO B cells were distinct from MZ B cell precursors in genetically
targeted animals, and that despite elevated surface expression
of CD21 in Klf2-deficient B cells, this receptor could be used to
properly identify FO B cells (Figure S2F). It should be noted
that a small number of AA4.1CD21hiIgMhi cells were detected
in the blood and lymph nodes of Klf2fl/fl; Cd19-Cre+/ miceImmunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc. 255
Figure 2. Genetically Targeted Animals
Have Increased Numbers of Splenic B Cells
(A) Mature splenic B cells (B220+ AA4.1) from
Klf2fl/fl; Cd19-Cre+/ (genetically targeted = cKO)
and Klf2fl/+; Cd19-Cre+/ (control) mice are dis-
played in terms of the lineage-defining markers
CD21, IgD, and IgM. The inner quadrant demar-
cates MZ B cells and their relative frequency.
n > 20 animals per group.
(B) Absolute AA4.1 B cell numbers from Klf2+/+;
Cd19-Cre+/ (black bars) and Klf2fl/fl; Cd19-
Cre+/ (red bars) animals are shown along with
significant p values. Error bars indicate the stan-
dard deviation. Note that blood is measured in
terms of volume instead of total tissue and is
displayed on an alternative scale (3105 per ml).
(MsLN, mesenteric lymph nodes; MZ, splenic MZ
B cells; and FO, splenic follicular B cells) n = 6
animals per group. p > 0.05 for blood and MsLN.
(C) Immunohistochemistry of spleens from
control and cKO mice, stained for B220+ (red)
andMOMA-1+ (green). The MOMA1+metallophilic
macrophages appear yellow in the overlay.
A white dashed line highlights the outer edge of
the MZ. MZ area was enumerated from ten sepa-
rate images and displayed as a bar graph with an
arbitrary scale (number of pixels). Error bars indi-
cate the standard deviation. n = 4 animals per
group.
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CD23 and IgD but not CD1d or CD9 (Figure S2G), indicating
that these were FO B lymphocytes and not aberrantly migrating
MZ B cells.
Immunohistochemistry confirmed that the MZ area was
increased in Klf2fl/fl; Cd19-Cre+/ animals relative to littermate
controls (Figure 2C). Using the MOMA1 antibody to identify met-
allophilic macrophages that border the marginal sinus, we found
increased numbers of cells expressing the pan-B cell marker,
B220, within the MZ. On the contrary, the follicular area was
not significantly altered (control = 1.4 ± 0.73 105, genetically tar-
geted mice = 2.0 ± 0.3 3 105 pixels, p = 0.16). Therefore, we
conclude that Klf2fl/fl; Cd19-Cre+/mice had increased numbers
of splenic B cells and that this correlated with a significantly
larger B cell-filled MZ.
Klf2 Differentially Regulates Chemokine Receptor
Expression on FO and MZ B Cells
Premature exit from bone marrow was suggestive of a Klf2-defi-
cient migratory defect. Moreover, it has been reported that
Klf2-deficient T cells aberrantly traffic because of inappropriately256 Immunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc.expressed migratory receptors (Bai et al.,
2007; Carlson et al., 2006; Sebzda et al.,
2008). When we examined B cell homing
receptors, we noted that Klf2-deficient
MZ B cells had reduced mRNA expres-
sion of C-X-C chemokine receptor 5
(CXCR5) and sphinogosine-1-phosphate
receptor 1 (S1P1) (Figure 3A). In contrast,
Klf2-deficient FO B cells upregulated
expression of these receptors. To deter-mine whether Klf2 was directly influencing CXCR5 and S1P1
transcription, we conducted chromatin immunoprecipitation
(ChIP) assays. Highly conserved, noncoding sequences that
contained the consensus Klf2 binding motif CACCC (Anderson
et al., 1995), proximal to CXCR5 and S1P1 transcriptional initia-
tion sites, were chosen as regulatory targets. Klf2 protein directly
bound to regulatory regions of CXCR5 andS1P1 inMZBcells but
not FO B cells (Figure 3B), which suggested that Klf2 directly
promoted CXCR5 and S1P1 transcription in MZ B cells and indi-
rectly repressed these receptors in FO B cells. To confirm that
altered transcription resulted in modified protein expression,
we examined receptor intensity by flow cytometry (Figure 3C).
Consistent with real-time polymerase chain reaction (PCR)
results, Klf2-deficient FO B cells expressed increased amounts
of CXCR5, whereas no changes were detected with antibodies
specific for CCR7 or CXCR4. Antibodies that recognize an extra-
cellular portion of S1P1 were not available so this receptor was
not examined with this technique. No consistent differences in
CXCR5 intensity were detected on Klf2-deficient MZ B cells by
flow cytometry, despite significant differences in mRNA expres-
sion. To address this apparent discrepancy, we conducted
Figure 3. Klf2 Regulates MZ and FO B Cell Homing Receptors
(A) MZ and FO B cells from Klf2+/+; Cd19-Cre+/ (control) and Klf2fl/fl; Cd19-Cre+/ (genetically targeted = cKO) mice were analyzed for B cell homing receptor
mRNA expression levels by real time PCR. Results are graphed as the fold change relative to control. p > 0.05 unless otherwise stated. This experiment was
repeated twice. Error bars indicate the standard deviation.
(B) Chromatin immunoprecipitation (ChIP) assays were performed on quiescent MZ (top panel) or FO B cells (lower panel) with primers specific for the regulatory
regions of CXCR5 and S1P1. ChIP assays with Klf2 antibody are shown in gray; assays with isotype control antibody are shown in black. Klf2 binding to the regu-
latory regions of CXCR5 or S1P1 is graphed relative to input amounts of these two sequences, respectively. This experiment was repeated twice.
(C) Surface expression of chemokine receptors on B cell populations are displayed as overlaid histograms. Results are representative of three independent
experiments.
(D) Chemokine or sphingolipid-mediated ex vivo B cell migration. Control (black) and cKO (red) B cells were placed in common transwell chambers andmigration
toward CXCL12 (CXCR4 ligand), CXCR13 (CXCR5 ligand), or S1P (S1P1 ligand) was measured. Asterisks (*) denote P values < 0.05. Migration assays using
CXCL12 were conducted twice; the other assays were done three times.
(E) B cell adhesion was measured by culturing unstimulated or pertussis toxin (PTX)-treated B cells in ICAM1-coated plates and analyzing adherent cells by flow
cytometry. Error bars indicate the standard deviation. This experiment was performed twice.
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Figure 4. Klf2-Deficient FO and MZ B Cells Are Subtly Repositioned
within the Spleen
(A) Immunohistochemistry of spleens from Klf2+/+; Cd19-Cre+/ (control) and
Klf2fl/fl; Cd19-Cre+/ (genetically targeted = cKO) animals that were previously
treated ± FTY720. A magnification that is 203 the original image is shown. MZ
B cells are detected with IgM antibody, FO B cells are detected using IgD anti-
body, and metallophilic macrophages are highlighted with MOMA-1 antibody.
These experiments were conducted twice.
(B) Flow cytometric analysis of splenic B cell lineages from control and cKO
mice ± FTY720 treatment. Triangles identify MZ B cells and their correspond-
ing frequencies (%). These data are representative of three experiments.
(C) FO B cell location relative to the MZ was analyzed by immunohistochem-
istry with tissue sections from control, cKO, and FTY720-treated cKO mice.
A magnification that is 403 the original image is shown. FO B cells are IgD+
and metallophilic macrophages are MOMA-1+. This experiment was
performed twice.
(D) Splenic B cell exposure to blood-borne antigen. Thirty minutes after intra-
venous injection of TNP-Ficoll, antigen surface binding was examined by flow
cytometry with a TNP-specific antibody. Histograms display TNP levels on
mature B cell lineages from control (solid gray) and cKO (red line) mice.
TNP-binding on Klf2+ MZ B cells (green line) and Klf2+ FO B cells (black line)
are shown in the left panel.
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mokine receptors on Klf2-deficient B cells. FO B cells from
genetically targeted mice displayed enhanced migration toward
the chemokine CXCL13 (Figure 3D). In contrast, Klf2-deficient
MZ B cell responses to this chemokine were diminished, indi-
cating that real-time PCR results correctly reflected homing
receptor expression. A similar dichotomy occurred with the
sphingolipid, S1P; Klf2-deficient FO B cells migrated more
robustly than control FO B cells, whereas Klf2-deficient MZ B
cells had a decreased response to this ligand relative to control
MZ B cells. These data suggest that Klf2 promotes or
suppresses chemokine-specific migration in MZ and FO B cells,
respectively.
Chemokine receptors activate integrins through a Gai
receptor-coupled signaling process (Kinashi, 2005), so B cell
adhesion was examined as an indirect measure of chemokine
receptor engagement. One of the primary integrins used by
both FO and MZ B cells is LFA-1 (aL+b2). With the LFA-1 ligand
ICAM1, ex vivo adhesion assays demonstrated enhanced
binding by Klf2-deficient FO, but not MZ, B cells (Figure 3E).
MZ B cells are particularly sensitive to the Gai inhibitor pertussis
toxin (Guinamard et al., 2000), and pretreatment with this drug
reduced MZ B cell adhesion. Consistent with Gai receptor-
coupled signaling promoting integrin activation, pretreated
Klf2-deficient FO B cells no longer expressed elevated adhesive
properties. Together with gene expression data and functional
migration studies, these experiments indicate that Klf2 differen-
tially regulates migratory receptors on FO and MZ B cells.
Klf2-Deficient FO and MZ B Cells Are Anatomically
Displaced within the Spleen
Differential regulation of chemokine receptors by Klf2 suggested
that FO and MZ B cell homing was disrupted in genetically tar-
geted mice. Therefore, splenic architecture was assessed with
antibodies that preferentially recognize MZ B cells (IgM) and
a subset of FO B cells (IgD). Gross examination showed that
Klf2-deficient MZ B cells were present in the MZ (Figure 4A).
However, closer inspection revealed that this IgM+ area was
discontinuous and often included overlap with MOMA1+ or
IgD+ cells. Together with functional migration studies, these
results suggest that Klf2 is required for efficient retention of
MZ B cells in the MZ. To determine whether these cells were
utilizing known homing receptors, we treated animals with
FTY720, an agonistic peptide that removes surface expression
of S1P1 (Chiba et al., 2006). Under these conditions, Klf2-
deficient MZ B cells completely vacated the MZ (Figure 4A, right
panel) yet remained within the spleen (Figure 4B). These data
suggested that Klf2-deficient MZ B cells still retained some
homeostatic homing receptors, but that these cells were more
inclined to enter B cell follicles than Klf2+ MZ B cells.
Despite subtle defects in MZ B cell migration, B220+ MZ areas
were increased in genetically targeted animals, suggesting the
presence of alternative B cell lineages within this zone. To test
this hypothesis, we costained splenic tissue sections for IgD
and MOMA1; anti-IgM antibody was excluded from this stain
to increase detection of FO B cells. Analysis of Klf2fl/+;
Cd19-Cre+/ control spleen showed a distinct separation
between FO B cells (green) and MZ specific macrophages
(red) (Figure 4C). In contrast, Klf2-deficient FO B cells converged258 Immunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc.with MZ macrophages, as evidenced by an orange hue in the
staining pattern. Treatment with FTY720 led to a clear separation
of FO B cells and MZ macrophages, suggesting that Klf2-defi-
cient FO B cells used S1P1 to enter and/or remain within the
MZ. To analyze dynamic FO B cell migration, we transferred
FO B cells from Klf2+/+; Cd19-Cre+/ or Klf2fl/fl; Cd19-Cre+/
Immunity
Klf2 Regulates B Cell Homing Patternsmice into C57Bl/6 recipient animals. As reported previously (van
Ewijk and van der Kwast, 1980), newly transferred Klf2+ FO B
cells efficiently entered splenic B cell follicles within 24 hr
(Figure S3A). In contrast, Klf2-deficient FO B cells were found
both within the B cell follicle and the surrounding MZ area.
When Klf2+ and Klf2-deficient FO B cells were cotransferred
into C57Bl/6 recipients (Figure S3B), these distinct migration
patterns became more apparent; Klf2+ FO B cells migrated
directly into splenic follicles, whereas the majority of transferred
Klf2-deficient cells remained within the MZ. In addition, FO B
cells from Klf2fl/fl; Cd19-Cre+/ donors were preferentially
retained within the spleen following transfer (Figure S3C), indi-
cating that this organ contains distinct anatomical properties
that favor Klf2-deficient B cell retention.
To functionally test whether Klf2-deficient FO B cells were in
the MZ, and thus in direct contact with blood-borne molecules,
we examined splenic B cell compartments after a 30 min expo-
sure to intravenously injected trinitrophenol (TNP)-coupled
Ficoll. Flow cytometric analysis showed that in control mice,
MZ B cells preferentially bound the hapten-carrier conjugate,
whereas both FO and MZ B cells quickly bound TNP-Ficoll in
genetically targeted animals (Figure 4D). Therefore, we conclude
that Klf2-deficient B cell migration was modified within the
spleen, allowing FOB cell encroachment into theMZ and access
to MZ-associated antigens.
Klf2 Is Not Required for Ex Vivo Humoral
Immune Responses
Such unusual B cell trafficking patterns raised the possibility that
humoral immunity was compromised in Klf2fl/fl; Cd19-Cre+/
mice. To address this issue, we first needed to determine
whether cell-intrinsic effector functions were intact in Klf2-defi-
cient B cells. Neither FO B cells nor MZ B cells harvested from
genetically targeted mice displayed variations in activation
markers (Figure S4A), suggesting B cell quiescence was not
disrupted. No significant differences in cell cycling were de-
tected when MZ and FO B cells were stimulated with various
regimens (Figure S4B). Moreover, titration curves of BCR-stimu-
lation demonstrated that Klf2+ and Klf2-deficient B cells had
identical activation thresholds (Figure S4C). In terms of ex vivo
immunoglobulin (Ig) isotype production, both control and
Klf2-deficient B cells responded to the TD antigen, ovalbumin
peptide, by class switching to IgG1 in a T cell-dependent manner
(Figure S5A). Likewise, type 1 TI (TI-1) antigenic responses,
induced either by LPS + IL4 or LPS alone, promoted class
switching to IgG1 or IgG3 in both cell populations (Figure S5B).
Klf2-deficient B cells also responded normally when stimulated
under type 2 (TI-2) antigenic conditions (Figure S5C) by
preferentially class switching to the IgG3 isotype. Enzyme-linked
immunosorbent assay (ELISA) measurements of Ig production
further confirmed that control and Klf2-deficient B cells
responded similarly to TI and TD ex vivo stimulation (Figure S5D).
These results led us to conclude that Klf2-deficient B cells had
normal cell-intrinsic effector functions.
Enhanced In Vivo Responses to TI-2 Antigens
in Genetically Targeted Mice
Having established that cell-intrinsic effector functions were
intact, we conducted experiments to determine whether Klf2-deficient B cell trafficking patterns affected in vivo humoral
responses. Total Ig levels were normal; however, sera IgM was
significantly increased in genetically targeted animals
(Figure 5A), which may reflect increased Klf2-deficient splenic
B cells numbers. As well, genetically targeted mice had
decreased amounts of serum IgA, an Ig isotype that is primarily
produced by B1 B cells under disease-free conditions (Kaminski
and Stavnezer, 2006; Kroese et al., 1989; Kunisawa et al., 2007;
Macpherson et al., 2000). Genetically targeted animals had very
few B1 B cells in the peritoneal cavity (Figures S6A and S6B),
which probably contributed to reduced amounts of serum IgA.
Mechanisms responsible for this B1 B cell defect are currently
being investigated. In this regard, limited numbers of B1 B cells
were found in the blood and spleen of genetically targeted mice
(Figure S6C) and Klf2-deficient B1 B cells could be generated
from bone marrow precursors with defined ex vivo techniques
(Montecino-Rodriguez and Dorshkind, 2006; Montecino-Rodri-
guez et al., 2006) (Figure S6D), suggesting that the defect was
migratory in nature. Cxcl13/ mice exhibit a similar defect in
peritoneal B1 B cells (Ansel et al., 2002), raising the possibility
that this lineage is particularly sensitive to trafficking defects.
Importantly, all other Ig isotypes were maintained at normal
levels, indicating that Klf2-deficient B cells did not undergo
excessive antigen-independent in vivo class switching.
The presence of Klf2-deficient FO B cells within the MZ raised
the possibility that TD antigen responses were compromised in
genetically targeted mice. However, when animals were chal-
lenged with ovalbumin peptide coupled to TNP, similar amounts
of total TNP-specific Ig were detected (Figure 5B). Likewise, the
preferential Ig isotype utilized during a TD immune response,
IgG1, was comparable between control and genetically targeted
animals. Statistical differences in IgM and IgA levels were
observed, which mirrored the previously noted differences in
basal serum antibody concentrations. Thus aberrant Klf2-defi-
cient B cell migration did not adversely affect B-T cell interac-
tions or TD immune reactions.
Given that Klf2-deficient MZ B cells exhibited a limited migra-
tory defect, we wanted to determine whether this affected TI
immune responses in vivo. No differences were detected when
mice were challenged with TNP-LPS (Figure 5C), indicating
that aberrant Klf2-deficient B cell migration did not inhibit TI-1
antigenic reactions. With regards to TI-2 antigen, mice were
challenged with TNP-Ficoll, a compound that preferentially acti-
vates MZ B cells and induces isotype class switching to IgG3
and to a lesser extent, IgG2a (Guinamard et al., 2000; Oliver
et al., 1997). Klf2fl/fl;Cd19-Cre+/mice responded more robustly
to TNP-Ficoll than control littermates, as measured by total
TNP-specific Ig levels (Figure 5D). ELISPOT experiments indi-
cated that elevated antibody concentrations were due to
increased frequencies of responding B cells (control = 58 ± 12
spot forming cells/106 splenocytes, genetically targeted mice =
106 ± 21 spot forming cells/106 splenocytes, p = 0.004) rather
than more Ig production per cell (control = 11 ± 2 3 103 mm2,
genetically targeted mice = 10 ± 1 3 103 mm2 mean spot size,
p = 0.19). Increased Ig levels resulted from enhanced production
of IgM and, unexpectedly, IgG1. Both FO and MZ B cells
produce IgM during an immune response; however, IgG1 is typi-
cally restricted to Th cell-mediated reactions. TNP-specific
IgG2a and IgG3 levels were comparable between control andImmunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc. 259
Figure 5. Klf2-Deficient B Cells Exhibit Enhanced
In Vivo TI-2 Immune Responses
Serum immunoglobulin (Ig) levels from Klf2+/+; Cd19-Cre+/
(control) and Klf2fl/fl; Cd19-Cre+/ (genetically targeted =
cKO) mice were measured by ELISA. Circles are individual
Ig levels per mouse; lines are the mean value for each data
set (n = 5 per group of mice unless stated otherwise). Data
are graphed as a function of optical density (OD 405nm).
p values are shown for each Ig isotype.
(A) Sera from unimmunized mice were measured for basal
levels of Ig isotypes. n = 9 mice per group.
(B) Mice were challenged with TNP-OVA to determine TD anti-
genic responses. Two weeks post-injection, Ig isotype levels
were measured. Similar results were achieved when this
experiment was repeated using the TD antigen, TNP-KLH.
(C) TI-1 antigenic responses were examined following
a 1 week challenge with TNP-LPS. This experiment was
repeated twice.
(D) TI-2 antigenic responses were measured with TNP-Ficoll.
One week after challenge, the various Ig isotype levels were
measured. This experiment was repeated four times.
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responses were intact. Therefore, we conclude that Klf2-defi-
cient B cells had an enhanced ability to respond to TI-2 antigens
in vivo, which included class switching to an isotype profile asso-
ciated with Th cell activity.
Klf2-Deficient FO B Cells Are Responsible
for Gain-of-Function Phenotypes
Subsequent studies were conducted to identify the B cell
compartment responsible for this unique humoral immune
response. Enhanced TI-2 reactions were not due to aberrant260 Immunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc.in vivo proliferation (Figure S7A) or survival
(Figure S7B) of either Klf2-deficient B cell lineage
and instead suggested that lineage-specific
migration defects contributed to this phenotype.
For instance, Klf2-deficient MZ B cells had
increased access to B cell follicles, which may
have enhanced their antigen-presenting capabil-
ities. Alternatively, MZ-associated Klf2-deficient
FO B cells may have reacted to TNP-Ficoll in
a T cell-dependent manner. To test this model,
we analyzed in vivo TI-2 reactions in intact or
T cell-depleted genetically targeted mice.
(Percentages of T cell populations in the blood of
Klf2fl/fl; CD19-Cre+/ animals were reduced from
41 ± 6 [CD4+] and 22 ± 2 [CD8+] to 0.06 ± 0.04
[CD4+] and 0.01 ± 0.02 [CD8+] after CD90.2 anti-
body treatment.) T cell depletion significantly
reduced Klf2-deficient B cell responses
(Figure 6A). Likewise, FTY720 treatment signifi-
cantly decreased TNP-specific Ig production in
genetically targeted mice. We attribute this
reduction in Ig production to Klf2-deficient B cell
exclusion from the MZ given that this drug did not
negatively affect ex vivo B cell activation or prolifer-
ation (Figure S7C). Therefore, these experiments
show that enhanced Klf2-deficient B cell
responses toward TI-2 antigen were both T celldependent and required access to the MZ, consistent with the
phenotypes observed in the FO B cell lineage.
Follicular B cells participate in germinal center (GC) formation
during T cell-dependent humoral immune responses. To assess
whether this occurred in genetically targeted mice challenged
with TI-2 antigen, we examined GC formation in draining lymph
nodes 1 week after TNP-Ficoll challenge (Figure 6B). Control
mice did not generate noticeable GCs, consistent with a MZ B
cell-dominated humoral response toward TI-2 antigens.
In contrast, B lymphocytes from genetically targeted animals
stained positively for GC markers. Immunohistochemistry
Figure 6. Characterization of Enhanced
Klf2-Deficient B Cell Responses toward
TI-2 Antigen
(A) Serum Ig levels from Klf2fl/fl; Cd19-Cre+/
(genetically targeted = cKO) (black), T cell-
depleted cKO (red), and FTY720-treated cKO
(blue) mice challenged with TNP-Ficoll. This
experiment was repeated twice.
(B) Germinal center formation in the draining lymph
nodes of TNP-Ficoll challenged mice. Mesenteric
lymph nodes from control, cKO, T cell-depleted
cKO, and FTY720-treated cKO mice were
analyzed for germinal center surface markers
(GL7+ and CD95+) 1 week after challenge.
Percentages of B220+AA4.1-GL7+CD95+ B cells
are shown. This experiment was performed twice
in triplicate; representative figures are shown.
(C) Humoral responses were measured in day 12
neonates challenged with TNP-Ficoll. The left
panels show the relative abundance of MZ B cells
(triangles) in control and cKO mice at the time of
analysis (day 19). This figure is representative of
six neonatal spleens, with three per group. The
right bar graph displays the amount of TNP-
specific IgM from control and cKO mouse sera.
(D) Germinal center formation was examined in
day 19 neonates after a 7 day challenge with
TNP-Ficoll. Mesenteric lymph nodes were exam-
ined for the germinal center surface markers GL7
and CD95 (percentages shown). Absolute
germinal center B cell (B220+AA4.1GL7+CD95+)
numbers are shown in the right bar graph. n = 3
per group. In all cases, error bars indicate the stan-
dard deviation.
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proliferating cells could be identified within the follicles of genet-
ically targetedmice (Figure S7D). GCB cells were located interior
to the MZ, adjacent to the T cell-rich periarteriolar lymphoid
sheath (PALS) (Figure S7E), suggesting that GC formation was
anatomically correct in Klf2fl/fl; Cd19-Cre+/ mice. T cell-
depleted genetically targeted animals challenged with TNP-Fi-
coll did not produce GCs (Figure 6B), confirming this process
was T cell dependent. To ensure that Klf2 excision within the B
cell compartment did not indirectly affect T cell-intrinsic effector
functions, we examined various elements of T cell homeostasis
in genetically targeted animals. Normal proportions of CD4+
and CD8+ T cells were found in secondary lymphoid organs
(Figure S7F) and splenic T cells correctly homed to PALS in
Klf2fl/fl; Cd19-Cre+/ mice (Figure S7G). Relative proportions of
regulatory T cells were also intact (Figure S7H), indicating that
B cell-specific Klf2-deficiency did not confer an overt hyperre-
sponsive phenotype to the T cell compartment. Instead, GC
formation was dependent upon B cell trafficking, as evidenced
by the absence of GC B cells in FTY720-treated animals
challenged with TNP-Ficoll (Figure 6B). These traits—a require-Immunity 33, 254–265ment for T cell interactions and access
to the MZ to generate GCs after TNP-
Ficoll challenge—were most consistent
with a homing defect in Klf2-deficient FO
B cells.To directly test whether FO B cells underpin the gain-of-func-
tion phenotype in genetically targeted mice, TI-2 reactivity was
examined in the absence of MZ B cells. Humoral responses
were examined in 12-day-old neonates given that it takes
approximately 3–4 weeks for MZ B cells to populate the spleen
(Martin and Kearney, 2002; Pillai et al., 2005). After a one-week
exposure to TNP-Ficoll, both control and genetically targeted
mice had very few MZ B cells present in the spleen
(Figure 6C); nevertheless, Klf2-deficient FO B cells still displayed
significantly enhanced TNP-specific humoral responses.
It should be noted that robust class switching did not occur at
this early time point in either control or genetically targeted
mice (data not shown), which may have reflected the still-devel-
oping architecture of the spleen (Pihlgren et al., 2003). However,
GC formation was more pronounced in genetically targeted
neonates (Figure 6D), suggestive of imminent class switching.
To prove that Klf2-deficient FO B cells directly interacted with
T cells during a TI-2 antigenic response, we cotransferred Klf2+
and Klf2-deficient FO B cells into adult C57Bl/6 recipient mice
and challenged them with TNP-Ficoll 24 hr later. Klf2+ FO B cells
did not form T cell conjugates, either spontaneously or after, August 27, 2010 ª2010 Elsevier Inc. 261
Figure 7. Genetically Targeted Mice Have
Enhanced Responsiveness against Borrelia
burgdorferi
(A) Bacterial titers in the bladders of Klf2+/+; Cd19-
Cre+/ (control) and Klf2fl/fl; Cd19-Cre+/
(cKO = genetically targeted) mice were measured
by real-time PCR one week after B. burgdorferi
infection. For comparison purposes, the relative
pathogen burden was set as 1.0 for the control
mice. n = 3 mice per group. Similar results were
obtained when this experiment was repeated.
Error bars indicate the standard deviation.
(B) ELISA measurements of Borrelia-specific anti-
body from the sera of infected control and cKO
animals. n = 5 mice per group. p > 0.05 except
where stated. This experiment was repeated
once, yielding similar results. Error bars indicate
the standard deviation.
(C) Ex vivo B cell recognition of B. burgdorferi was
examined with MZ and FO B cells from the spleens
of infected animals. After a brief incubation with
B. burgdorferi lysate, Klf2+ andKlf2-deficient B cells
were examined by flow cytometry with B. burgdor-
feriantibody.Quadrantsshowthe relative frequency
of Borrelia-binding B cells. These contour blots are
representative of eight mice, with four per group.
(D) Analysis of germinal center formation in draining
lymph nodes of infected control and cKO animals.
Germinal center B cells (CD19+AA4.1GL7+CD95+)
are outlinedwith corresponding frequencies. These
figures are representative of eight mice, with four
per group. This experiment was repeated twice.
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Klf2 Regulates B Cell Homing Patternsantigen challenge, whereas Klf2-deficient FO B cells formed
CD4+ T cell conjugates in a TNP-Ficoll-responsive manner (Fig-
ure S7I). These data demonstrate that subsequent to TNP-Ficoll
exposure in the MZ, Klf2-deficient FO B cells are able to interact
with CD4+ T cells in the spleen. Thus, a mechanistic link can be
made between the homing properties of Klf2-deficient FO B cell
and the ability of Klf2fl/fl; Cd19-Cre+/ mice to respond to TI-2
antigens in a TD manner.Klf2-Deficient FO B Cells Respond to MZ-Associated
Pathogens
The biological importance of this phenotype was examined by
challenging genetically targeted mice with Borrelia burgdorferi,
an infectious spirochete bacterium responsible for Lyme disease
in humans (Barbour and Hayes, 1986; Steere, 1989). Mouse
studies have revealed that MZ B cells play a critical role in the262 Immunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc.initial humoral response to this pathogen
(Belperron et al., 2007; McKisic and Bart-
hold, 2000). Seven days after infection,
genetically targeted mice displayed
enhanced clearance of B. burgdorferi
relative to littermate controls (Figure 7A).
Analysis of B. burgdorferi-specific anti-
body showed increased amounts of
IgG1 in experimental sera, whereas
IgG2a and IgG3 concentrations were
comparable between control and geneti-cally targeted mice (Figure 7B). IgA levels were decreased in
Klf2fl/fl; Cd19-Cre+/ mice, which we attributed to a lack of B1 B
cells. To demonstrate that this gain of function was due to
increased Klf2-deficient FO B cell recognition of the pathogen,
we incubated infected splenicBcells fromcontrol andgenetically
targeted animals ex vivo with B. burgdorferi lysate, then stained
them with Borrelia-specific antibody (Figure 7C). Both Klf2+ and
Klf2-deficient MZ B cells displayed equivalent staining patterns.
In contrast, Klf2-deficient FO B cells had an increased frequency
of pathogen recognition relative to Klf2+ FO B cells, indicative of
privileged access to MZ-associated pathogens. Moreover, anal-
ysis of draining lymph nodes from infected animals revealed that
genetically targeted mice produced more GC B cells than litter-
mate controls (Figure 7D), suggesting that enhanced pathogen
clearance utilized a T cell-dependent mechanism. These results
confirmed that in the absence of Klf2, FO B cells have enhanced
responsiveness toward MZ-associated pathogens.
Immunity
Klf2 Regulates B Cell Homing PatternsDISCUSSION
Klf2 is involved in numerous biological processes including
vascular development (Kuo et al., 1997a; Lee et al., 2006; Wani
et al., 1998), primitive erythropoiesis (Basu et al., 2007), mono-
cyte activation (Das et al., 2006), and T cell homeostasis
(Bai et al., 2007; Carlson et al., 2006; Kuo et al., 1997b; Sebzda
et al., 2008). Robust expression of this transcription factor in B
lymphocytes has suggested a critical role for Klf2 in B cells as
well; however, genetic evidence has been lacking. Here, we
report that Klf2 excision in the B cell compartment leads to
defects in homeostasis, cellular trafficking, and humoral immu-
nity. Together, this work furthers our knowledge of chemokine
receptor regulation and reveals how B cell migration imposes
constraints on pathogen recognition.
Although Klf2 expression is first detected in pre-B cells, it does
not appear to be required for early B cell development. Instead,
Klf2-deficient B cell phenotypes are consistent with a late-stage
defect in retention and recirculation to the bone marrow. More-
over, mature splenic B cell lineages are expanded in genetically
targeted mice. Increased Klf2-deficient MZ B cell numbers may
result from selective pressure tomaintain normal serum antibody
levels (Lopes-Carvalho and Kearney, 2004). Severely reduced
B1 B cell numbers and the accompanying reduction in natural
Abs produced by this lineage (Ansel et al., 2002; Hayakawa
et al., 1984) may stimulate additional MZ B cell generation. Alter-
natively, premature egress from the bone marrow may dispro-
portionately induce a surge in MZ B cell generation (Martin and
Kearney, 2002). Unlike MZ B cells, FO B cells circulate
throughout secondary lymphoid organs. Despite this, increased
FO B cell numbers are limited to the spleen, suggesting that
tissue-restricted factors normally utilized by Klf2+ MZ B cells
are involved in Klf2-deficient FO B cell retention.
Klf2 excision results in differential regulation of homing recep-
tors in closely related lymphocyte lineages. However, Klf2-defi-
cient MZ B cells still responded ex vivo to S1P and in vivo to
FTY720, indicating that these cells retain some functional S1P-
sensitive homing receptors. Klf2-deficient MZ B cells also
express less CXCR5, a chemokine receptor used to shuttle acti-
vated MZ B cells into follicles (Cinamon et al., 2008), which may
partially negate the effects of decreased S1P1 expression. With
regard to FO B cells, a considerable number of Klf2-deficient
cells are able to remain within the MZ, possibly due to increased
expression of S1P1 and enhanced integrin activation. At the
same time, increased CXCR5 levels on Klf2-deficient FO B cells
probably allows these cells to eventually recirculate. Therefore,
we conclude that dysregulated expression of migratory recep-
tors disrupts the well-defined anatomical separation of MZ and
FO B cells in Klf2fl/fl; Cd19-Cre+/ mice.
Hypothetically, merging B cell populations might have
impaired humoral activities. Instead, in vivo TI-2 antigenic
responses were enhanced in genetically targeted mice. This
was not simply a reflection of increased splenic B cell numbers
because TI-1 antigenic reactions were unaffected. With regards
to TI-2 antigenic reactivity, Klf2-deficient FO B cells were prob-
ably causal, as evidenced by: (1) in vivo gain-of-function pheno-
types included recognition of MZ-associated antigens; (2)
enhanced responsiveness was T cell dependent and required B
cell access to MZs; (3) these events were associated with GCformation; and (4) GC formation and increased production of
TI-2-specific Ig occurred in genetically targeted neonates that
lacked MZ B cells. These experiments also suggest that unlike
MZ B cells, FO B cells are ‘‘hardwired’’ to require Th cell signals
during a TI-2 response, regardless of anatomical location.
Klf2excision results in increased surface expressionofCD21on
MZ and FO B cells. Because this molecule acts as a coreceptor
that can potently lower activation thresholds (Fearon and Carroll,
2000), there is the formal possibility that CD21 contributes to
some of the gain-of-function phenotypes seen in genetically tar-
geted mice. However, multiple independent assays indicate that
cell-intrinsic properties (excluding homing receptor expression)
are normal in Klf2-deficient B cells, including proliferation, isotype
class switching, and immunoglobulin production. Moreover, gain-
of-function phenotypes are restricted to TI-2 antigens, confined to
the FOB cell lineage, and depend upon anatomical location. All of
these attributes are best described in terms of aberrant migration
patterns exhibited by Klf2-deficient FO B cells.
Klf2fl/fl; Cd19-Cre+/ mice clear B. burgdorferimore efficiently
than control littermates, demonstrating the physiological advan-
tage of allowing FO B cell access to the MZ. Given that blood-
borne bacteria are widely prevalent and in some cases life
threatening, why are Klf2+ FO B cells removed from MZs? FO
B cell retention within the MZ may increase the risk of T cell-
mediated autoimmunity. Autoreactive BCR-transgenic B cells
have been shown to quickly (2–3 days) prime self-reactive
T cells following in vivo antigen challenge (Yan et al., 2006),
suggesting a role for MZ B cells in breaking peripheral tolerance
to blood-borne particles. In this regard, the BCR repertoire of MZ
B cells is limited relative to FO B cells (Carey et al., 2008;
Dammers et al., 2000). Therefore, it is possible that FOB cell traf-
ficking into the MZ is restricted to reduce self-antigen recogni-
tion and autoreactive T cell induction. Because B cell malignancy
and autoreactivity are associatedwith theMZ (Ferreri and Zucca,
2007; Lopes-Carvalho and Kearney, 2005; Viau and Zouali,
2005), studies examining B cell retention within this compart-
ment may offer new clinical insights. This is especially relevant
in light of the gain-of-function phenotypes exhibited by
MZ-associated FO B cells in genetically targeted animals.
EXPERIMENTAL PROCEDURES
Mice
Klf2fl/fl; Cd19Cre+/ mice were generated by mating Klf2fl/fl mice (Lee et al.,
2006) with Cd19-Cre+ mice (The Jackson Laboratory). OTII transgenic mice
were obtained from Taconic. Mice were housed in pathogen-free conditions
at Vanderbilt University Medical Center according to National Institutes of
Health guidelines and approved institutional animal committee protocols.
Flow Cytometry
B cell populations were identified as previously described (Hoek et al., 2009).
Additional antibodies used for characterizing B cell populations include: CD1d,
CD9, CD25, CD44, CD45RB, CD62L, CD69, CD80, CD86, CD95, GL7, a4+b7
integrin, CXCR4, CXCR5 (BD Biosciences), and CCR7 (eBioscience). Intracel-
lular Klf2 was measured with polyclonal rabbit anti-Klf2 (Schuh et al., 2008).
Data were acquired on a five-laser BD Bioscences Life Science Research II
flow cytometer and analyzed with the FlowJo software package (TreeStar).
Real-Time PCR
RNA was extracted from sorted B cells with an RNeasy Micro Kit (QIAGEN).
cDNA was generated with a SuperScript VILO cDNA synthesis kit (Invitrogen),Immunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc. 263
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mix (Applied Biosystems). Data were acquired on an iCycler iQ Real-Time PCR
Detection System (BioRad). Primers used (forward + reverse) are as follows:
Klf2: 50-CACCAACTGCGGCAAGACCTAC-30 + 50-TCTGTGACCTGTGTG
CTTTCGG-30
CXCR4: 50-AGCTAAGGAGCATGACGGACAAGT-30 + 50-AACGTGCTGTA
GAGGTTGACAGT-30
CXCR5: 50-AAGCGGAAACTAGAGCCTGGTTCA-30 + 50-ACCATCCCATC
ACAAGCATCGGTA-30
CCR7: 50-CCAGACCGTGGCAATTTCAACAT-30 + 50-ACAAGAAAGGGT
TGACACAGCAGC-30
S1P1: 5
0-GTGTAGACCCAGAGTCCTGCG-30 + 50-AGCTTTTCCTTGGCTG
GAGAG-30
Data is expressed as:2 [^(CT for Klf2-deficient experimental gene – CT for
Klf2-deficient Gapdh) – (CT for control experimental gene – CT for control
Gapdh)]. Burden levels of B. burgdorferi were measured in a similar manner,
with the bacterial recA gene and the eukaryotic tubulin gene.
ChIP Assay
MZ and FO B cells (6 3 106) were sorted from C57Bl/6 mice, and chromatin
immunoprecipitation (ChIP) assays were performed with the EZ-ChIP kit (Milli-
pore) according to the manufacturer’s protocol. Immunoprecipitations were
performed with anti-Klf2 (Santa Cruz) or rabbit IgG control antibody. The
following primer sets amplified DNA from Klf2 pulldowns: CXCR5 50:
GCTTGCCTCTCGACTCATCT, CXCR5 30: GCACTGAAATGCTTGCGTAG,
S1P1 5
0: TGAAGAGGCCTTGGTCAGAT, and S1P1 30: TTGAAACTGCACAGC
AGAGG.
Immunofluorescent Microscopy
Spleen sectionswere prepared and analyzed as previously described (Acevedo-
Suarezetal., 2005).Bcellswere identifiedwithB220, IgD,and IgMantibodies (BD
Biosciences), andMZwas delineatedwithMOMA1 antibody (Cedar Lane Labs).
In Vitro Migration Assays
Migration assays were conducted as previous described (Sebzda et al., 2008).
Input and migrated cells were identified with IgM, CD21, CD23, AA4.1, and
CD19 antibodies. The percentage of migration = 100% 3 ((experimental
number – background number)/total input).
In Vitro Adhesion Assay
Splenocytes from control or genetically targeted mice were placed in ICAM1-
coated six-well plates (107/well) and allowed to settle at 37C for 90 min. Wells
were filled, sealed, inverted, and left at room temperature for 30 min. Media
was removed, wells rinsed, and remaining cells analyzed by flow cytometry.
Alternatively, splenocytes from genetically targeted mice were pretreated
with pertussis toxin (20 ng/ml; Sigma) for 1 hr at 37C. The percentage of adhe-
sion = 100% 3 (ICAM1-coated well – uncoated well)/total input. Wells were
performed in triplicate.
Immunizations
For TI immune responses, mice were immunized intraperitoneally (i.p.) with
1 mg/kg TNP-LPS or 10 mg/kg TNP-Ficoll in 100 ml PBS, and bled 7 days after
immunization for measurement of primary immune responses. In some experi-
ments, mice were treated with FTY720 (Cayman Chemical Company; 2 mg/ml
indrinkingwater) or anti-CD90.2 (BioLegend; 2doses, 250mg i.p. onconsecutive
days) prior to immunization. For TD immune responses, mice were immunized
i.p. with 10 mg/kg TNP-Ovalbumin (TNP-Ova) in Alum (1:1, Alum:PBS; 100 ml
per mouse) and bled 14 days after immunization. For B. burgdorferi, mice were
intradermally inoculated with 1 3 104 spirochetes from a low-passage clinical
isolate and bled 7 days after immunization for measurement of primary immune
responses.
ELISA
ELISA was performed as previously described (Hoek et al., 2009). For B. burg-
dorferi-specific ELISA, plates were coated with B. burgdorferi lysate (3 mg in
50 ml of 100% ethanol per well), and serum was diluted 1:25–1:1000.264 Immunity 33, 254–265, August 27, 2010 ª2010 Elsevier Inc.ELISPOT
Millipore Immobilon-P 96-well plates were coated with 10 mg/ml TNP-BSA,
blocked with 10% FCS, and total splenocytes (1 3 106 cells per well) from
mice immunized for 7 days with TNP-Ficoll were cultured in the absence of
additional stimulation. Cells were removed and bound TNP-specific Ig was
quantified with horseradish peroxidase-conjugated goat anti-mouse Ig.
Statistical Analysis
Data were analyzed with a two-tailed Student’s t test. Values p % 0.05 were
considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at doi:10.1016/j.
immuni.2010.07.016.
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